Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium

Journal of Affective Disorders

Volumn 191, Issue , 2016, Pages 256-273

  Ketter, Terence A ^a   Miller, Shefali ^a   Dell'Osso, Bernardo ^a,b   Wang, Po W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bipolar disorder; Lithium; Quetiapine; Randomized controlled trial; Real world practice

Indexed keywords

LITHIUM; QUETIAPINE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; COMPARATIVE EFFECTIVENESS; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HUMAN; MAINTENANCE THERAPY; MIXED MANIA AND DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; THYROID DISEASE; TREMOR; WEIGHT GAIN; XEROSTOMIA; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL (TOPIC); COMBINATION DRUG THERAPY; FEMALE; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; QUETIAPINE FUMARATE; YOUNG ADULT;

EID: 84960929440     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.11.002     Document Type: Review

References (61)

1. A.C. Altamura, E. Mundo, B. Dell'Osso, G. Tacchini, M. Buoli, and J.R. Calabrese Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study J. Affect. Disord. 110 2008 135 141
2. R.J. Baldessarini, E. Vieta, J.R. Calabrese, M. Tohen, and C.L. Bowden Bipolar depression: overview and commentary Harv. Rev. Psychiatry 18 2010 143 157
3. W.V. Bobo, N.A. Reilly-Harrington, T.A. Ketter, B.D. Brody, G. Kinrys, D.E. Kemp, R.C. Shelton, S.L. McElroy, L.G. Sylvia, J.H. Kocsis, M.G. McInnis, E.S. Friedman, V. Singh, M. Tohen, C.L. Bowden, T. Deckersbach, J.R. Calabrese, M.E. Thase, A.A. Nierenberg, D.J. Rabideau, D.A. Schoenfeld, S.V. Faraone, and M. Kamali Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial J. Affect. Disord. 161 2014 30 35
4. D.J. Bond, M. Kauer-Sant'Anna, R.W. Lam, and L.N. Yatham Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) J. Affect. Disord. 124 2010 108 117
5. M.S. Bourin, E. Severus, J.P. Schronen, P. Gass, J. Szamosi, H. Eriksson, and H. Chandrashekar Lithium as add-on to quetiapine XR in adult patients with acute mania: A 6-week, multicenter, double-blind, randomized, placebo-controlled study Int. J. Bipolar. Disord. 2 2014 14
6. C.L. Bowden, H. Grunze, J. Mullen, M. Brecher, B. Paulsson, M. Jones, M. Vagero, and K. Svensson A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder J. Clin. Psychiatry 66 2005 111 121
7. J.R. Calabrese, P.E. Keck Jr., W. Macfadden, M. Minkwitz, T.A. Ketter, R.H. Weisler, A.J. Cutler, R. McCoy, E. Wilson, and J. Mullen A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am. J. Psychiatry 162 2005 1351 1360
8. F. Centorrino, A. Ventriglio, A. Vincenti, A. Talamo, and R.J. Baldessarini Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004 Hum. Psychopharmacol. 25 2010 179 186
9. E. Choong, G. Bondolfi, M. Etter, F. Jermann, J.M. Aubry, J. Bartolomei, M. Gholam-Rezaee, and C.B. Eap Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population J. Psychiatr. Res. 46 2012 540 548
10. G. Curran, and A. Ravindran Lithium for bipolar disorder: A review of the recent literature Expert Rev. Neurother. 14 2014 1079 1098
11. T.M. Dando, and G.M. Keating Quetiapine: A review of its use in acute mania and depression associated with bipolar disorder Drugs 65 2005 2533 2551
12. D. Dikeos, M.G. Badr, F. Yang, M.B. Pesek, Z. Fabian, G. Tapia-Paniagua, C. Hudita, T. Okasha, Y. D'yachkova, G. Harrison, and T. Treuer Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics World J. Biol. Psychiatry 11 2010 667 676
13. E.S. Friedman, J.R. Calabrese, T.A. Ketter, A.C. Leon, M.E. Thase, C.L. Bowden, L.G. Sylvia, M.J. Ostracher, J. Severe, D.V. Iosifescu, A.A. Nierenberg, and N.A. Reilly-Harrington Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials J. Affect. Disord. 152-154 2014 97 104
14. J.R. Geddes, G.M. Goodwin, J. Rendell, J.M. Azorin, A. Cipriani, M.J. Ostacher, R. Morriss, N. Alder, and E. Juszczak Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial Lancet 375 2010 385 395
15. G.M. Goodwin Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology J. Psychopharmacol. 23 2009 346 388
16. P. Grof, and B. Muller-Oerlinghausen A critical appraisal of lithium's efficacy and effectiveness: the last 60 years Bipolar. Disord. 11 Suppl. 2 2009 S10 S19
17. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania World J. Biol. Psychiatry 10 2009 85 116
18. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression World J. Biol. Psychiatry 11 2010 81 109
19. H. Grunze, E. Vieta, G.M. Goodwin, C. Bowden, R.W. Licht, H.J. Moller, and S. Kasper The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder World J. Biol. Psychiatry 14 2013 154 219
20. M.C. Hardoy, A. Garofalo, B. Carpiniello, J.R. Calabrese, and M.G. Carta Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder Clin. Pract. Epidemiol. Ment. Health 1 2005 7
21. Hirschfeld, R.M.A., 2007. Guideline Watch (November 2005): Practice Guideline for the Treatment of Patients With Bipolar Disorder, 2nd Edition. In: Focus, vol. 5, pp. 34-39.
22. F. Hooshmand, S. Miller, J. Dore, P.W. Wang, S.J. Hill, N. Portillo, and T.A. Ketter Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011 J. Affect. Disord. 155 2014 283 287
23. International Consensus Group International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression J. Clin. Psychiatry 69 2008 1632 1646
24. T.A. Ketter, and D.W. Haupt Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice Curr. Med. Res. Opin. 22 2006 2345 2353
25. S.J. Kim, Y.J. Lee, Y.J. Lee, and S.J. Cho Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression J. Affect. Disord. 157 2014 33 40
26. R.M. Klok, A.F. Al Hadithy, N.P. van Schayk, A.J. Antonisse, J.J. Caro, J.R. Brouwers, and M.J. Postma Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder Expert Rev. Pharmacoecon. Outcomes Res. 7 2007 459 467
27. H. Li, C. Ma, G. Wang, X. Zhu, M. Peng, and N. Gu Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: A randomized and double-blind study Curr. Med. Res. Opin. 24 2008 1 10
28. Lithium citrate tetrahydrate, 2013. Lithium Citrate Tetrahydrate (Summary of Product Characteristics), Rosemont Pharmaceuticals Ltd., Leeds, UK
29. S.L. McElroy, R.H. Weisler, W. Chang, B. Olausson, B. Paulsson, M. Brecher, V. Agambaram, C. Merideth, A. Nordenhem, and A.H. Young A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II) J. Clin. Psychiatry 71 2010 163 174
30. R.S. McIntyre, M. Brecher, B. Paulsson, K. Huizar, and J. Mullen Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial Eur. Neuropsychopharmacol. 15 2005 573 585
31. National Collaborating Centre for Mental Health (UK), 2006. Bipolar disorder: the management of bipolar disorders in adults, children and adolescents, in primary and secondary care. NICE clinical Guidelines, No. 38. British Psychological Society. Available at: (http://www.ncbi.nlm.nih.gov/books/NBK55364/) (accessed on 10.08.15).
32. A. Nierenberg Bipolar CHOICE (Clinical Health Outcomes Initiative for Comparative Effectiveness) 2014 American Society of Clinical Psychopharmacology Hollywood, FL June 16-19
33. A.A. Nierenberg, L.G. Sylvia, A.C. Leon, N.A. Reilly-Harrington, L.W. Shesler, S.L. McElroy, E.S. Friedman, M.E. Thase, R.C. Shelton, C.L. Bowden, M. Tohen, V. Singh, T. Deckersbach, T.A. Ketter, J.H. Kocsis, M.G. McInnis, D. Schoenfeld, W.V. Bobo, and J.R. Calabrese Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder Clin. Trials 11 2014 114 127
34. W.A. Nolen, and R.H. Weisler The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: A post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144) Bipolar. Disord. 15 2013 100 109
35. I. Pacchiarotti, D.J. Bond, R.J. Baldessarini, W.A. Nolen, H. Grunze, R.W. Licht, R.M. Post, M. Berk, G.M. Goodwin, G.S. Sachs, L. Tondo, R.L. Findling, E.A. Youngstrom, M. Tohen, J. Undurraga, A. Gonzalez-Pinto, J.F. Goldberg, A. Yildiz, L.L. Altshuler, J.R. Calabrese, P.B. Mitchell, M.E. Thase, A. Koukopoulos, F. Colom, M.A. Frye, G.S. Malhi, K.N. Fountoulakis, G. Vazquez, R.H. Perlis, T.A. Ketter, F. Cassidy, H. Akiskal, J.M. Azorin, M. Valenti, D.H. Mazzei, B. Lafer, T. Kato, L. Mazzarini, A. Martinez-Aran, G. Parker, D. Souery, A. Ozerdem, S.L. McElroy, P. Girardi, M. Bauer, L.N. Yatham, C.A. Zarate, A.A. Nierenberg, B. Birmaher, S. Kanba, R.S. El-Mallakh, A. Serretti, Z. Rihmer, A.H. Young, G.D. Kotzalidis, G.M. MacQueen, C.L. Bowden, S.N. Ghaemi, C. Lopez-Jaramillo, J. Rybakowski, K. Ha, G. Perugi, S. Kasper, J.D. Amsterdam, R.M. Hirschfeld, F. Kapczinski, and E. Vieta The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders Am. J. Psychiatry 170 2013 1249 1262
36. A. Pfennig, T. Bschor, P. Falkai, and M. Bauer The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline Dtsch. Arztebl. Int. 110 2013 92 100
37. J. Pillarella, A. Higashi, G.C. Alexander, and R. Conti Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009 Psychiatr. Serv. 63 2012 83 86
38. S.G. Potkin, P.T. Thyrum, R. Bera, D. Carreon, G. Alva, A.H. Kalali, and C. Yeh Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability Clin. Ther. 24 2002 1809 1823
39. M. Prabhakar, W.G. Haynes, W.H. Coryell, E.A. Chrischilles, dD. Miller, S. Arndt, V.L. Ellingrod, L. Warren, and J.G. Fiedorowicz Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders Pharmacotherapy 31 2011 806 812
40. Quetiapine fumarate prescribing information (Seroquel), 2013. AstraZeneca Pharmaceuticals, Wilmington, DE.
41. Quetiapine fumarate extended release prescribing information (Seroquel XR), 2013. AstraZeneca Pharmaceuticals, Wilmington, DE.
42. G. Sachs, K.N. Chengappa, T. Suppes, J.A. Mullen, M. Brecher, N.A. Devine, and D.E. Sweitzer Quetiapine with lithium or divalproex for the treatment of bipolar mania: A randomized, double-blind, placebo-controlled study Bipolar. Disord. 6 2004 213 223
43. M. Sanford, and G.M. Keating Quetiapine: A review of its use in the management of bipolar depression CNS Drugs 26 2012 435 460
44. K.N. Sokolski, and T.F. Denson Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 863 866
45. M. Stedman, H.M. Pettinati, E.S. Brown, M. Kotz, J.R. Calabrese, and S. Raines A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence Alcohol. Clin. Exp. Res. 34 2010 1822 1831
46. T. Suppes, C. Datto, M. Minkwitz, A. Nordenhem, C. Walker, and D. Darko Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression J. Affect. Disord. 121 2010 106 115
47. T. Suppes, E.B. Dennehy, R.M. Hirschfeld, L.L. Altshuler, C.L. Bowden, J.R. Calabrese, M.L. Crismon, T.A. Ketter, G.S. Sachs, and A.C. Swann The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder J. Clin. Psychiatry 66 2005 870 886
48. T. Suppes, D.I. Kelly, P.E. Keck Jr., S.L. McElroy, L.L. Altshuler, J. Mintz, M.A. Frye, W.A. Nolen, D.A. Luckenbaugh, R.M. Post, G.S. Leverich, R.W. Kupka, and H. Grunze Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network Int. Clin. Psychopharmacol. 22 2007 376 381
49. T. Suppes, E. Vieta, U. Gustafsson, and B. Ekholm Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: Analysis of two large randomized, placebo-controlled trials Depress. Anxiety 30 2013 1089 1098
50. T. Suppes, E. Vieta, S. Liu, M. Brecher, and B. Paulsson Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127) Am. J. Psychiatry 166 2009 476 488
51. L.G. Sylvia, N.A. Reilly-Harrington, A.C. Leon, C.I. Kansky, J.R. Calabrese, C.L. Bowden, T.A. Ketter, E.S. Friedman, D.V. Iosifescu, M.E. Thase, M.J. Ostacher, M. Keyes, D. Rabideau, and A.A. Nierenberg Medication adherence in a comparative effectiveness trial for bipolar disorder Acta Psychiatr. Scand. 129 2014 359 365
52. M.E. Thase, W. Macfadden, R.H. Weisler, W. Chang, B. Paulsson, A. Khan, and J.R. Calabrese Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study) J. Clin. Psychopharmacol. 26 2006 600 609
53. E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson, and M. Brecher Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126) J. Affect. Disord. 109 2008 251 263
54. R.H. Weisler, W.A. Nolen, A. Neijber, A. Hellqvist, and B. Paulsson Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: A randomized controlled study) J. Clin. Psychiatry 72 2011 1452 1464
55. L.N. Yatham, S.H. Kennedy, S.V. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O'Donovan, G. Macqueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, R. Milev, D.J. Bond, B.N. Frey, B.I. Goldstein, B. Lafer, B. Birmaher, K. Ha, W.A. Nolen, and M. Berk Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar. Disord. 15 2013 1 44
56. L.N. Yatham, B. Paulsson, J. Mullen, and A.M. Vagero Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania J. Clin. Psychopharmacol. 24 2004 599 606
57. L.N. Yatham, E. Vieta, A.H. Young, H.J. Moller, B. Paulsson, and M. Vagero A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania Int. Clin. Psychopharmacol. 22 2007 212 220
58. Young, A.H., Calabrese, J.R., Gustafson, U., Berk, M., McElroy, S.L., Thase, M.E., Suppes, T., Earley, W., 2013. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. Int. J. Bipolar Discord. 1, 10
59. Young, A.H., McElroy, S.L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., 2010. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I), J. Clin. Psychiatry 71, 150-162
60. A.H. Young, S.L. McElroy, B. Olausson, and B. Paulsson A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder World J. Biol. Psychiatry 15 2014 96 112
61. M. Yumru, H.A. Savas, E. Kurt, M.C. Kaya, S. Selek, E. Savas, E.T. Oral, and I. Atagun Atypical antipsychotics related metabolic syndrome in bipolar patients J. Affect. Disord. 98 2007 247 252